Public Health and Smoking Cessation

Quitting the habit means fighting nicotine addiction. "It's not like drinking, where you have a huge social drinking population of nonaddicted people. People who smoke regularly tend to be addicted," says Timothy Baker, associate director, University of Wisconsin Center for Tobacco Research and Intervention. With nearly half the US adult population lighting up in 2000, public-health researchers are hard-pressed to figure out what helps--and what doesn't--in the fight against nicotine addictio

Written byMignon Fogarty
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Quitting the habit means fighting nicotine addiction. "It's not like drinking, where you have a huge social drinking population of nonaddicted people. People who smoke regularly tend to be addicted," says Timothy Baker, associate director, University of Wisconsin Center for Tobacco Research and Intervention.

With nearly half the US adult population lighting up in 2000, public-health researchers are hard-pressed to figure out what helps--and what doesn't--in the fight against nicotine addiction.

BIG BROTHER Laws and taxes. "The two things that have the biggest and most immediate effect on smoking are ... smoke-free workplaces and restaurants, and (cigarette) tax increases," says Stanton Glantz, director, Center for Tobacco Control Research and Education, University of California, San Francisco. For example, Glantz's recent paper1 showed that when workplaces become smoke-free, workers almost immediately smoke 29% fewer cigarettes per day. Glantz says getting such a dramatic effect through cigarette taxes could require increases of as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies